BUY TIRZEMED (GIP and GLP-1 Receptor Agonist)
€100.00
WHAT IS TIRZEMED (GIP and GLP-1 Receptor Agonist)?
Tirzemed is a peptide that acts as a dual agonist for GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors. These receptors play critical roles in regulating blood sugar levels, and the dual action enhances the body’s ability to control glucose. It also has strong weight-loss effects due to its impact on appetite regulation and metabolism. TIRZEMED BENE
Description
WHAT IS TIRZEMED (GIP and GLP-1 Receptor Agonist)?
Tirzemed acts as a dual agonist targeting both GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors, two pathways central to blood sugar regulation. Its dual mechanism is associated with enhanced glucose control alongside effects on appetite regulation and metabolism relevant to weight management.
Specifications
| Attribute | Detail |
|---|---|
| Active Ingredient | GIP and GLP-1 Receptor Agonist |
| Format | Injectable, vial |
| Strength | 10 mg per vial |
| Package Content | 1 box, 1 vial |
Use Profile
Blood Sugar Regulation — Associated with enhanced insulin secretion and reduced glucagon release
Weight Management — Associated with appetite regulation and metabolic effects
Cardiovascular Marker Support — Associated with cholesterol and blood pressure effects
Anti-Inflammatory Association — Associated with reduced inflammation markers
Important Information
Consult a Doctor: Use under the guidance of a healthcare provider, particularly with underlying medical conditions or medications.
Administration: Administered via subcutaneous injection, typically on a weekly schedule.
Purity and Authenticity: Source from a reputable supplier to ensure product purity and authenticity.
Legal Status: Not approved for human consumption by regulatory agencies in most jurisdictions outside of prescribed medical use; intended for research purposes only. Confirm local laws and regulations before purchase or use.
Storage
Store below 30°C. Protect from light. Do not freeze.
FAQ
What is Tirzemed?
A peptide that acts as a dual GIP and GLP-1 receptor agonist, associated with blood sugar regulation and weight management effects.
How is Tirzemed administered?
Via subcutaneous injection, typically once weekly.
Disclaimer
This product is not approved for human consumption by regulatory agencies in most jurisdictions outside of prescribed medical use and is intended for research purposes only. Always follow the guidance of a healthcare provider and adhere to local laws and regulations.
HOW TO USE TIRZEMED PEPTIDE:
Tirzemed is injected subcutaneously, generally once per week. The dosage should be adjusted based on blood glucose control and side effects.
Reviews
There are no reviews yet.